Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins

Br J Haematol. 1994 Nov;88(3):618-20. doi: 10.1111/j.1365-2141.1994.tb05083.x.

Abstract

Seven patients with chronic immune thrombocytopenic purpura (ITP) were treated with intramuscular anti-D (anti-D IgG) five times, on an alternate-day basis, or until a platelet count of 100 x 10(9)/l was achieved, and, subsequently, when necessary to maintain platelet counts above 50 x 10(9)/l. Five patients responded to therapy, two of whom entered long-term remission. Although signs of haemolysis were present in all patients, anaemia was never a problem. No patient developed haematomas at the site of injection. We suggest that intramuscular anti-D represents a safe and relatively inexpensive alternative to intravenous gamma globulins (IVGG) for children with severe chronic ITP.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Child
  • Chronic Disease
  • Female
  • Humans
  • Injections, Intramuscular
  • Male
  • Platelet Count
  • Purpura, Thrombocytopenic, Idiopathic / therapy*
  • Rho(D) Immune Globulin / administration & dosage
  • Rho(D) Immune Globulin / therapeutic use*

Substances

  • Rho(D) Immune Globulin